Compare
Trane Technologies plc vs Danaher Corp vs KLA Corp vs Thermo Fisher Scientific Inc.
| Latest fiscal year | Trane Technologies plc TT | Danaher Corp DHR | KLA Corp KLAC | Thermo Fisher Scientific Inc. TMO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | $21.32B | $24.57B | $13.58B | $44.56B |
| Revenue growth (YoY) | +7.5% | +2.9% | +11.7% | +3.9% |
| Gross margin | n/a | 59.1% | 61.3% (computed) | n/a |
| Operating margin | 18.6% | 19.1% | n/a | 17.4% |
| Net margin | 13.7% | 14.7% | 35.6% | 15.0% |
| Net income | $2.92B | $3.61B | $4.83B | $6.70B |
| EPS (Diluted) | $12.98 | $5.05 | $3.66 | $17.74 |
| Operating cash flow | $3.22B | $6.42B | $4.14B | $7.82B |
| Free cash flow | $2.84B | $5.26B | $3.77B | $6.29B |
| Cash & equivalents | $1.76B | n/a | $1.65B | $9.85B |
| Total assets | $21.42B | $83.46B | $17.95B | $110.34B |
| Total liabilities | $12.82B | n/a | $11.60B | n/a |
| Shareholders' equity | $8.60B | $52.53B | $6.35B | $53.41B |
| Return on year-end equity | 33.9% | 6.9% | 76.1% | 12.6% |
| Shares outstanding | n/a | 706.90M | 1.31B | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Trane Technologies plc | Danaher Corp | KLA Corp | Thermo Fisher Scientific Inc. |
|---|---|---|---|---|
| Latest | $21.32B Ended 2025-12-31 | $24.57B Ended 2025-12-31 | $13.58B Ended 2026-06-30 | $44.56B Ended 2025-12-31 |
| 1 year earlier | $19.84B Ended 2024-12-31 | $23.88B Ended 2024-12-31 | $12.16B Ended 2025-06-30 | $42.88B Ended 2024-12-31 |
| 2 years earlier | $17.68B Ended 2023-12-31 | $23.89B Ended 2023-12-31 | $9.81B Ended 2024-06-30 | $42.86B Ended 2023-12-31 |
| 3 years earlier | $15.99B Ended 2022-12-31 | $26.64B Ended 2022-12-31 | $10.50B Ended 2023-06-30 | $44.91B Ended 2022-12-31 |
| 4 years earlier | $14.14B Ended 2021-12-31 | $24.80B Ended 2021-12-31 | $9.21B Ended 2022-06-30 | $39.21B Ended 2021-12-31 |